share_log

AbbVie | 4: Statement of changes in beneficial ownership of securities-Director Quaggin Susan E

SEC ·  Oct 3 05:05

Summary by Futu AI

Susan E Quaggin, reported a transaction with AbbVie Inc. [ABBV] on September 30, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and post-transaction holdings were not disclosed in the announcement. The relationship of Susan E Quaggin to the issuer was not specified.
Susan E Quaggin, reported a transaction with AbbVie Inc. [ABBV] on September 30, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and post-transaction holdings were not disclosed in the announcement. The relationship of Susan E Quaggin to the issuer was not specified.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Related Stocks Related Stocks
    Symbol Mini Chart Latest Price
    MIRA Pharmaceuticals
    MIRA
    -- 1.060
    Medicus Pharma
    MDCX
    -- 2.580
    AbbVie
    ABBV
    -- 175.580
    Pfizer
    PFE
    -- 26.360
    Bristol-Myers Squibb
    BMY
    -- 57.330

    Unlock the Full List